Skip to content
10-Q

Quarterly Report

ENDRA Life Sciences Inc. NDRA

0001213900-25-110887

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 14, 2025 1.17M sh
Shares Diluted Q3 2025 · Sep 30, 2025 761.22K sh
Shares Diluted Q3 2025 · Sep 30, 2025 679.21K sh
Shares Diluted Q3 2025 · Sep 30, 2024 246.82K sh
Shares Diluted Q3 2025 · Sep 30, 2024 89.59K sh
Capex Q3 2025 · Sep 30, 2025 $17.28K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$3.57M
Stockholders Equity Q3 2025 · Sep 30, 2025 $171.38K
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.47M
Stockholders Equity Q3 2025 · Dec 31, 2024 $2.56M
Current Liabilities Q3 2025 · Sep 30, 2025 $800.31K
Current Liabilities Q3 2025 · Dec 31, 2024 $605.23K
Total Liabilities Q3 2025 · Sep 30, 2025 $1.79M
Total Liabilities Q3 2025 · Dec 31, 2024 $1.89M
Current Assets Q3 2025 · Sep 30, 2025 $1.05M
Current Assets Q3 2025 · Dec 31, 2024 $3.43M
Total Assets Q3 2025 · Sep 30, 2025 $1.96M
Total Assets Q3 2025 · Dec 31, 2024 $4.45M
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.10
Eps Diluted Q3 2025 · Sep 30, 2025 −$5.68
Eps Diluted Q3 2025 · Sep 30, 2024 −$9.54
Eps Diluted Q3 2025 · Sep 30, 2024 −$82.14
Eps Basic Q3 2025 · Sep 30, 2025 −$2.10
Eps Basic Q3 2025 · Sep 30, 2025 −$5.68
Eps Basic Q3 2025 · Sep 30, 2024 −$9.54
Eps Basic Q3 2025 · Sep 30, 2024 −$82.14
Sga Expense Q3 2025 · Sep 30, 2025 $893.31K
Sga Expense Q3 2025 · Sep 30, 2025 $2.62M
Rd Expense Q3 2025 · Sep 30, 2025 $432.11K
Rd Expense Q3 2025 · Sep 30, 2025 $1.34M
Net Income Q3 2025 · Sep 30, 2025 −$1.6M
Net Income Q3 2025 · Sep 30, 2025 −$3.86M
Operating Income Q3 2025 · Sep 30, 2025 −$1.37M
Operating Income Q3 2025 · Sep 30, 2025 −$4.14M